# TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors

> **NCT01245985** · PHASE2 · TERMINATED · sponsor: **Heidelberg University** · enrollment: 8 (actual)

## Conditions studied

- Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal Cancer

## Interventions

- **RADIATION:** carbon ion boost

## Key facts

- **NCT ID:** NCT01245985
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2012-11
- **Final completion:** 2013-11
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** slow recruitment (only 8 patients recruited and treated until 12/2012)
- **Last updated:** 2013-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01245985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01245985, "TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01245985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*